Genome-wide association study implicates NDST3 in schizophrenia and bipolar disorder

Todd Lencz, Saurav Guha, Chunyu Liu, Jeffrey Rosenfeld, Semanti Mukherjee, Pamela DeRosse, Majnu John, Lijun Cheng, Chunling Zhang, Judith A. Badner, Masashi Ikeda, Nakao Iwata, Sven Cichon, Marcella Rietschel, Markus M. Nöthen, A. T.A. Cheng, Colin Hodgkinson, Qiaoping Yuan, John M. Kane, Annette T. Lee & 6 others Anne Pisanté, Peter K. Gregersen, Itsik Pe'er, Anil K. Malhotra, David Goldman, Ariel Darvasi

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

Schizophrenia and bipolar disorder are major psychiatric disorders with high heritability and overlapping genetic variance. Here we perform a genome-wide association study in an ethnically homogeneous cohort of 904 schizophrenia cases and 1,640 controls drawn from the Ashkenazi Jewish population. We identify a novel genome-wide significant risk locus at chromosome 4q26, demonstrating the potential advantages of this founder population for gene discovery. The top single-nucleotide polymorphism (SNP; rs11098403) demonstrates consistent effects across 11 replication and extension cohorts, totalling 23, 191 samples across multiple ethnicities, regardless of diagnosis (schizophrenia or bipolar disorder), resulting in Pmeta = 9.49 × 10-12 (odds ratio (OR) = 1.13, 95% confidence interval (CI): 1.08-1.17) across both disorders and Pmeta = 2.67 × 10 -8 (OR = 1.15, 95% CI: 1.08-1.21) for schizophrenia alone. In addition, this intergenic SNP significantly predicts postmortem cerebellar gene expression of NDST3, which encodes an enzyme critical to heparan sulphate metabolism. Heparan sulphate binding is critical to neurite outgrowth, axon formation and synaptic processes thought to be aberrant in these disorders.

Original languageEnglish
Article number2739
JournalNature Communications
Volume4
DOIs
Publication statusPublished - 01-12-2013

Fingerprint

schizophrenia
genome
Genome-Wide Association Study
Bipolar Disorder
Schizophrenia
Heparitin Sulfate
Genes
disorders
Single Nucleotide Polymorphism
Odds Ratio
Confidence Intervals
Chromosomes
confidence
sulfates
Polymorphism
Metabolism
Gene expression
Genetic Association Studies
intervals
axons

All Science Journal Classification (ASJC) codes

  • Chemistry(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Physics and Astronomy(all)

Cite this

Lencz, T., Guha, S., Liu, C., Rosenfeld, J., Mukherjee, S., DeRosse, P., ... Darvasi, A. (2013). Genome-wide association study implicates NDST3 in schizophrenia and bipolar disorder. Nature Communications, 4, [2739]. https://doi.org/10.1038/ncomms3739
Lencz, Todd ; Guha, Saurav ; Liu, Chunyu ; Rosenfeld, Jeffrey ; Mukherjee, Semanti ; DeRosse, Pamela ; John, Majnu ; Cheng, Lijun ; Zhang, Chunling ; Badner, Judith A. ; Ikeda, Masashi ; Iwata, Nakao ; Cichon, Sven ; Rietschel, Marcella ; Nöthen, Markus M. ; Cheng, A. T.A. ; Hodgkinson, Colin ; Yuan, Qiaoping ; Kane, John M. ; Lee, Annette T. ; Pisanté, Anne ; Gregersen, Peter K. ; Pe'er, Itsik ; Malhotra, Anil K. ; Goldman, David ; Darvasi, Ariel. / Genome-wide association study implicates NDST3 in schizophrenia and bipolar disorder. In: Nature Communications. 2013 ; Vol. 4.
@article{e69376bf12294881920c798b340f55e9,
title = "Genome-wide association study implicates NDST3 in schizophrenia and bipolar disorder",
abstract = "Schizophrenia and bipolar disorder are major psychiatric disorders with high heritability and overlapping genetic variance. Here we perform a genome-wide association study in an ethnically homogeneous cohort of 904 schizophrenia cases and 1,640 controls drawn from the Ashkenazi Jewish population. We identify a novel genome-wide significant risk locus at chromosome 4q26, demonstrating the potential advantages of this founder population for gene discovery. The top single-nucleotide polymorphism (SNP; rs11098403) demonstrates consistent effects across 11 replication and extension cohorts, totalling 23, 191 samples across multiple ethnicities, regardless of diagnosis (schizophrenia or bipolar disorder), resulting in Pmeta = 9.49 × 10-12 (odds ratio (OR) = 1.13, 95{\%} confidence interval (CI): 1.08-1.17) across both disorders and Pmeta = 2.67 × 10 -8 (OR = 1.15, 95{\%} CI: 1.08-1.21) for schizophrenia alone. In addition, this intergenic SNP significantly predicts postmortem cerebellar gene expression of NDST3, which encodes an enzyme critical to heparan sulphate metabolism. Heparan sulphate binding is critical to neurite outgrowth, axon formation and synaptic processes thought to be aberrant in these disorders.",
author = "Todd Lencz and Saurav Guha and Chunyu Liu and Jeffrey Rosenfeld and Semanti Mukherjee and Pamela DeRosse and Majnu John and Lijun Cheng and Chunling Zhang and Badner, {Judith A.} and Masashi Ikeda and Nakao Iwata and Sven Cichon and Marcella Rietschel and N{\"o}then, {Markus M.} and Cheng, {A. T.A.} and Colin Hodgkinson and Qiaoping Yuan and Kane, {John M.} and Lee, {Annette T.} and Anne Pisant{\'e} and Gregersen, {Peter K.} and Itsik Pe'er and Malhotra, {Anil K.} and David Goldman and Ariel Darvasi",
year = "2013",
month = "12",
day = "1",
doi = "10.1038/ncomms3739",
language = "English",
volume = "4",
journal = "Nature Communications",
issn = "2041-1723",
publisher = "Nature Publishing Group",

}

Lencz, T, Guha, S, Liu, C, Rosenfeld, J, Mukherjee, S, DeRosse, P, John, M, Cheng, L, Zhang, C, Badner, JA, Ikeda, M, Iwata, N, Cichon, S, Rietschel, M, Nöthen, MM, Cheng, ATA, Hodgkinson, C, Yuan, Q, Kane, JM, Lee, AT, Pisanté, A, Gregersen, PK, Pe'er, I, Malhotra, AK, Goldman, D & Darvasi, A 2013, 'Genome-wide association study implicates NDST3 in schizophrenia and bipolar disorder', Nature Communications, vol. 4, 2739. https://doi.org/10.1038/ncomms3739

Genome-wide association study implicates NDST3 in schizophrenia and bipolar disorder. / Lencz, Todd; Guha, Saurav; Liu, Chunyu; Rosenfeld, Jeffrey; Mukherjee, Semanti; DeRosse, Pamela; John, Majnu; Cheng, Lijun; Zhang, Chunling; Badner, Judith A.; Ikeda, Masashi; Iwata, Nakao; Cichon, Sven; Rietschel, Marcella; Nöthen, Markus M.; Cheng, A. T.A.; Hodgkinson, Colin; Yuan, Qiaoping; Kane, John M.; Lee, Annette T.; Pisanté, Anne; Gregersen, Peter K.; Pe'er, Itsik; Malhotra, Anil K.; Goldman, David; Darvasi, Ariel.

In: Nature Communications, Vol. 4, 2739, 01.12.2013.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Genome-wide association study implicates NDST3 in schizophrenia and bipolar disorder

AU - Lencz, Todd

AU - Guha, Saurav

AU - Liu, Chunyu

AU - Rosenfeld, Jeffrey

AU - Mukherjee, Semanti

AU - DeRosse, Pamela

AU - John, Majnu

AU - Cheng, Lijun

AU - Zhang, Chunling

AU - Badner, Judith A.

AU - Ikeda, Masashi

AU - Iwata, Nakao

AU - Cichon, Sven

AU - Rietschel, Marcella

AU - Nöthen, Markus M.

AU - Cheng, A. T.A.

AU - Hodgkinson, Colin

AU - Yuan, Qiaoping

AU - Kane, John M.

AU - Lee, Annette T.

AU - Pisanté, Anne

AU - Gregersen, Peter K.

AU - Pe'er, Itsik

AU - Malhotra, Anil K.

AU - Goldman, David

AU - Darvasi, Ariel

PY - 2013/12/1

Y1 - 2013/12/1

N2 - Schizophrenia and bipolar disorder are major psychiatric disorders with high heritability and overlapping genetic variance. Here we perform a genome-wide association study in an ethnically homogeneous cohort of 904 schizophrenia cases and 1,640 controls drawn from the Ashkenazi Jewish population. We identify a novel genome-wide significant risk locus at chromosome 4q26, demonstrating the potential advantages of this founder population for gene discovery. The top single-nucleotide polymorphism (SNP; rs11098403) demonstrates consistent effects across 11 replication and extension cohorts, totalling 23, 191 samples across multiple ethnicities, regardless of diagnosis (schizophrenia or bipolar disorder), resulting in Pmeta = 9.49 × 10-12 (odds ratio (OR) = 1.13, 95% confidence interval (CI): 1.08-1.17) across both disorders and Pmeta = 2.67 × 10 -8 (OR = 1.15, 95% CI: 1.08-1.21) for schizophrenia alone. In addition, this intergenic SNP significantly predicts postmortem cerebellar gene expression of NDST3, which encodes an enzyme critical to heparan sulphate metabolism. Heparan sulphate binding is critical to neurite outgrowth, axon formation and synaptic processes thought to be aberrant in these disorders.

AB - Schizophrenia and bipolar disorder are major psychiatric disorders with high heritability and overlapping genetic variance. Here we perform a genome-wide association study in an ethnically homogeneous cohort of 904 schizophrenia cases and 1,640 controls drawn from the Ashkenazi Jewish population. We identify a novel genome-wide significant risk locus at chromosome 4q26, demonstrating the potential advantages of this founder population for gene discovery. The top single-nucleotide polymorphism (SNP; rs11098403) demonstrates consistent effects across 11 replication and extension cohorts, totalling 23, 191 samples across multiple ethnicities, regardless of diagnosis (schizophrenia or bipolar disorder), resulting in Pmeta = 9.49 × 10-12 (odds ratio (OR) = 1.13, 95% confidence interval (CI): 1.08-1.17) across both disorders and Pmeta = 2.67 × 10 -8 (OR = 1.15, 95% CI: 1.08-1.21) for schizophrenia alone. In addition, this intergenic SNP significantly predicts postmortem cerebellar gene expression of NDST3, which encodes an enzyme critical to heparan sulphate metabolism. Heparan sulphate binding is critical to neurite outgrowth, axon formation and synaptic processes thought to be aberrant in these disorders.

UR - http://www.scopus.com/inward/record.url?scp=84893361550&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893361550&partnerID=8YFLogxK

U2 - 10.1038/ncomms3739

DO - 10.1038/ncomms3739

M3 - Article

VL - 4

JO - Nature Communications

JF - Nature Communications

SN - 2041-1723

M1 - 2739

ER -